Life Science

Description : We supply high-efficiency magnesium sulphate monohydrate (CAS No: 14168-73-1) archieved across international commodity exchanges as mineral kieserite, dried magnesium sulphate, and high-density granular MgSO₄·H₂O to optimise nutrient efficiency and processing yields in the global agricultural blending, polymer manufacturing, and paper pulp sectors. Perfectly enhanced for structural integrity and stable, mid-rate dissolution, our industrial-grade magnesium sulphate monohydrate provides a concentrated source of highly bioavailable magnesium and sulphur. As global agricultural supply chains move away from low-density, moisture-heavy heptahydrate salts to reduce international ocean freight overhead, blending facilities are modifying their compound infrastructure. Large-scale fertiliser producers are upgrading their dry-bulk operations by sourcing our strictly controlled, free-flowing granular monohydrate. International agribusiness networks and polymer compounders partner with us as their certified global magnesium sulphate monohydrate supplier to guarantee reliable material sizing and uninterrupted bulk allocation. As global environmental protocols demand higher nitrogen-use efficiency in commercial crops, choosing us as your primary magnesium sulphate monohydrate supplier delivers the specific chlorophyll-building block needed to accelerate plant protein synthesis. Sourcing managers can readily audit our continuous production tolerances by downloading the batch-specific Magnesium Sulphate Monohydrate COA and TDS sheets, which verify exact fractional ratios of water-soluble magnesium oxide (MgO) and sulphur (S). Reviewing our official Magnesium Sulphate Monohydrate COA and TDS documentation ensures complete regulatory compliance across border customs and establishes a clear technical baseline for continuous bulk compounding. Contact us as your dedicated magnesium sulphate monohydrate supplier to organise automated logistics routing for international procurement.

Description : Our Trilaciclib API intermediate portfolio offers high-performance building blocks for the synthesis of the first-in-class, FDA-approved CDK4/6 inhibitor designed to protect bone marrow during chemotherapy. Trilaciclib (a kinase inhibitor used to reduce chemotherapy-induced myelosuppression) requires high-purity building blocks. Trilaciclib Advanced Intermediate 1 (CAS 2170746-95-7) & Trilaciclib Spiro-Core 2 (CAS 866620-36-2) represent critical milestones in the convergent synthesis of the spiro-pyrazino-pyrrolo-pyrimidine scaffold. Int -1 is synthesized through the condensation of 2-(methylthio)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid and 1-aminomethyl-1-cyclohexanol. Int - 2 is then produced via a base-catalyzed internal cyclization of Intermediate 1, effectively locking the spiro-cyclohexane ring into the pyrazino-pyrrolo-pyrimidine framework. This "protection-free" methodology is preferred in 2026 for its high atom economy and reduced step-count compared to the original research routes. We utilise advanced spirocyclic construction and regioselective amination protocols to ensure these intermediates meet the stringent impurity profiles required for GMP-compliant drug substance manufacturing. Our manufacturing infrastructure is engineered for process safety and scalability, delivering high-purity solids with consistent (PSD). We are established global Trilaciclib intermediates supplier at 99%+ purity, ensuring minimal carry-over of methylthio-related impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and semi-finished formulation suppliers, providing comprehensive analytical (HPLC/NMR/MS) and supporting quality assurance documentation (COA/TDS/SDS) across all grades, detailed impurity mapping; and region-specific regulatory support. We ensure reliable lead times from R&D quantities through commercial-scale manufacturing, enabling partners to meet diverse global and regional requirements.

Description : Our Trilaciclib API intermediate portfolio offers high-performance building blocks for the synthesis of the first-in-class, FDA-approved CDK4/6 inhibitor designed to protect bone marrow during chemotherapy. Trilaciclib (a kinase inhibitor used to reduce chemotherapy-induced myelosuppression) requires high-purity building blocks. Trilaciclib Advanced Intermediate 1 (CAS 2170746-95-7) & Trilaciclib Spiro-Core 2 (CAS 866620-36-2) represent critical milestones in the convergent synthesis of the spiro-pyrazino-pyrrolo-pyrimidine scaffold. Int -1 is synthesized through the condensation of 2-(methylthio)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid and 1-aminomethyl-1-cyclohexanol. Int - 2 is then produced via a base-catalyzed internal cyclization of Intermediate 1, effectively locking the spiro-cyclohexane ring into the pyrazino-pyrrolo-pyrimidine framework. This "protection-free" methodology is preferred in 2026 for its high atom economy and reduced step-count compared to the original research routes. We utilise advanced spirocyclic construction and regioselective amination protocols to ensure these intermediates meet the stringent impurity profiles required for GMP-compliant drug substance manufacturing. Our manufacturing infrastructure is engineered for process safety and scalability, delivering high-purity solids with consistent (PSD). We are established global Trilaciclib intermediates supplier at 99%+ purity, ensuring minimal carry-over of methylthio-related impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and semi-finished formulation suppliers, providing comprehensive analytical (HPLC/NMR/MS) and supporting quality assurance documentation (COA/TDS/SDS) across all grades, detailed impurity mapping; and region-specific regulatory support. We ensure reliable lead times from R&D quantities through commercial-scale manufacturing, enabling partners to meet diverse global and regional requirements.

Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market, primarily utilized for the synthesis of complex nitro-substituted aromatic compounds and radiopharmaceuticals for neuroimaging where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are essential to ensure reaction efficiency. 4-Nitrobenzoyl chloride serves as a high-performance precursor in the current shift toward strategic global sourcing, as CDMOs increasingly require custom synthesis services that provide rigorous impurity profiling and analytical validation to meet stringent regulatory and environmental standards. 4-Nitrobenzoic acid chloride remains a preferred choice for advanced process development and bulk chemical supplier procurement, reflecting a growing industry demand for reliable precursors that optimize yields in large-scale commercial manufacturing of dyes and specialty polymers while maintaining precise crystalline morphology for downstream stability (Pharma/API purity 99% | General Industry purity 98%). We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting P-Nitrobenzoyl Chloride COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Description : 3-(4-Chlorophenyl)glutaric acid (CAS 35271-74-0) is a pivotal building block in the API intermediates market, primarily serving as the essential precursor for the synthesis of the muscle relaxant Baclofen, where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are required to meet strict USP and EP quality standards. 3-(4-Chlorophenyl)pentanedioic acid functions as a high-performance intermediate in the evolving custom synthesis services landscape, as CDMOs prioritize strategic global sourcing and rigorous analytical validation to optimize reaction yields and purity profiles in large-scale pharmaceutical manufacturing. 3-(4-Cl-Phenyl)glutaric acid remains a preferred choice for advanced process development and bulk chemical supplier procurement, reflecting the industry's shift toward reliable precursors that offer precise crystalline morphology and long-term stability for complex organic synthesis and agrochemical applications (Pharma/API purity 99% | General Industry purity 98%). We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 3-(4-Chloro Phenyl) Glutaric Acid COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Description : 4-(2-Aminoethyl)benzene sulfonamide (CAS 35303-76-5) serves as a critical structural component within the API intermediates market, primarily as a high-performance precursor for second-generation sulfonylurea antidiabetics like Glipizide and Gliquidone where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are vital for metabolic efficacy. Benzenesulfonamide, 4-(2-aminoethyl)- is experiencing heightened demand as CDMOs prioritize custom synthesis services to achieve rigorous crystalline morphology and impurity profiling, reflecting a broader industry pivot toward strategic global sourcing of high-quality building blocks. 4-Sulfamoylphenethylamine remains a preferred choice for advanced process development and bulk chemical supplier procurement due to its versatile utility in synthesizing complex sulfonamide-based pharmaceuticals that must meet stringent international regulatory standards (Pharma/API purity 99% | General Industry purity 98%). We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-(2-Aminoethyl)benzene sulfonamide COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Description : 4-Hydroxypyridine-3-sulfonic acid (CAS 51498-37-4) acts as a pivotal building block within the API intermediates market, primarily utilized for the synthesis of Torsemide and other pyridine-based diuretics where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are essential for meeting stringent pharmacopeial standards. 4-Pyridinol-3-sulfonic acid serves as a high-performance precursor for custom synthesis services, as global CDMOs increasingly prioritize rigorous impurity profiling and analytical validation to align with current shifts toward strategic global sourcing and enhanced regulatory oversight. 4-Hydroxy-3-pyridinesulfonic acid remains a preferred choice for advanced process development and bulk chemical supplier procurement, reflecting a growing industry demand for reliable precursors that optimize yields in large-scale commercial manufacturing while maintaining precise crystalline morphology for downstream stability (Pharma/API purity 99% | General Industry purity 98%). We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-Hydroxypyridine-3-sulfonic acid COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Description : 4,4'-Diaminobenzanilide (CAS 785-30-8) serves as a vital aromatic diamine in the API intermediates market, where its structural rigidity is leveraged by CDMOs to synthesize high-performance polymers and specialty pharmaceutical compounds requiring Pharma/API purity 99% | General Industry purity 98%. 4-Amino-N-(4-aminophenyl)benzamide is increasingly sought through custom synthesis services as global sourcing shifts prioritize suppliers who offer rigorous impurity profiling and analytical validation to meet evolving regulatory compliance standards for advanced materials. 4-Aminobenzoyl-4'-aminoanilide remains a cornerstone for a bulk chemical supplier focusing on the synthesis of eco-friendly direct dyes and high-performance pigments, reflecting a market trend toward sustainable high purity fine chemicals that reduce environmental impact during large-scale manufacturing (Pharma/API purity 99% | General Industry purity 98%). We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4,4'-Diaminobenzanilide COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Description : Salcaprozate Sodium (CAS No: 203787-91-1) serves as a specialized oral delivery excipient and permeation enhancer, operating by buffering local gastric pH and facilitating non-covalent lipophilic complexation to enable transcellular absorption of macromolecules and therapeutic peptides. The commercial landscape for high-purity salcaprozate sodium within the contract development and manufacturing organization (CDMO) sector is accelerating due to the rising adoption of oral peptide therapeutics and expanded clinical pipelines targeting metabolic disorders. Industrial production demands optimized synthetic routes involving the condensation of salicylamide or salicylic acid derivatives with aliphatic chains, requiring rigorous control over impurity profiles and crystallization kinetics to meet strict pharmaceutical standards. As a globally established Salcaprozate Sodium supplier with high purity levels, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Salcaprozate Sodium CoA and Salcaprozate Sodium TDS across all grades. Beyond supply, we support partners through the entire product sourcing framework from scouting, process development, pilot-to-commercial manufacturing. We support procurement with region specific compliances, GMP quality assurance, regulatory documentation, global supply chain capabilities and logistics coordination being a recognised Snac Supplier.

Description : 4-Chloropyrrolo[2,1-f][1,2,4]triazine serves as a critical halogenated heterocycle and key bicyclic building block within modern medicinal chemistry, primarily deployed in nucleoside analogue manufacturing and advanced kinase inhibitor synthesis such as AAK1 targeting platforms. Global demand across Contract Development and Manufacturing Organisations (CDMOs) continues to expand, driven by the strategic utility of its reactive C4-chloro substituent in nucleophilic aromatic substitution reactions to construct complex, bio-active medicinal scaffold architectures. Recent supply chain dynamics underscore an increasing emphasis on high-purity, tightly controlled isomer profiles to prevent downstream impurity carry-over during commercial scale-up and process optimisation of critical therapeutic APIs. We are a globally established 4-Chloropyrrolo(2,1-f)(1,2,4)triazine intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-Chloropyrrolo(2,1-f)(1,2,4)triazine COA/TDS/SDS region-specific regulatory support. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.